Are statins really wonder drugs?

J Formos Med Assoc. 2014 Dec;113(12):892-8. doi: 10.1016/j.jfma.2013.05.016. Epub 2013 Nov 11.

Abstract

Statins [3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase], are wonder drugs that have reshaped the treatment of hypercholesterolemia and associated cardiovascular diseases. However, evidence from various studies indicates existence of many statin-induced side effects such as myopathies, rhabdomyolysis, hepatotoxicity, peripheral neuropathy, impaired myocardial contractility, diabetes, autoimmune diseases, and erectile dysfunction (ED). Physician awareness of these side effects is reported to be very low even for the adverse effects (AEs) most widely reported by patients. This can lead to incorrect treatment decisions, compromised patient care, and an increase in patient morbidity. Therefore, the aim of this article is to highlight the AEs of statin therapy as well as rational management of these complications to further improve safety of these excellent drugs.

Keywords: adverse effects; diabetes; hepatotoxicity; myopathy; neuropathy; statins.

Publication types

  • Review

MeSH terms

  • Chemical and Drug Induced Liver Injury / etiology
  • Diabetes Mellitus / chemically induced
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Inflammation / chemically induced
  • Kidney Diseases / chemically induced
  • Muscular Diseases / chemically induced*
  • Nervous System Diseases / chemically induced

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors